Magnera CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
MAGN
Magnera CORPMagnera Corporation's Q2 2026 Form 10-Q filing reveals a 2% increase in net sales to $857 million, though the company reported a net loss of $20 million.
NYSE
MAGN
Magnera CORPMagnera Corporation reported a 3% decrease in net sales for the second quarter of fiscal year 2026, but saw a significant improvement in operating income due to cost management and integration efficiencies.
NYSE
MAGN
Magnera CORPMagnera Corporation reported a significant increase in net sales and a return to operating income in its first fiscal quarter, despite ongoing net losses and internal control deficiencies.
NYSE
MAGN
Magnera CORPMagnera Corporation reported a net loss of $18 million for the quarter ended June 28, 2025, despite a 51% increase in net sales driven by the Glatfelter acquisition.
NYSE
MAGN
Magnera CORPMagnera Corporation's Q2 2025 results reflect the impact of the Glatfelter acquisition and general market softness, leading to a net loss despite increased net sales.
NYSE
MAGN
Magnera CORPMagnera Corporation's Q1 2025 results reflect the impact of the recent acquisition of Glatfelter, with increased net sales but also higher operating losses.
NYSE
MAGN
Magnera CORPGlatfelter Corporation announced its third quarter 2024 results, showing a net loss but also progress in its merger with Berry Global's HHNF segment.
NYSE
MAGN
Magnera CORPGlatfelter Corporation announced its second quarter 2024 financial results, showing a net loss but improved operating income, while also progressing with its planned merger with Berry Global's Health, Hygiene and Specialties segment.
NYSE
MAGN
Magnera CORPGlatfelter Corporation reported a net loss for the first quarter of 2024, impacted by lower sales volumes and higher interest expenses, while also progressing with its planned merger with Berry Global's Health, Hygiene and Specialties segment.